Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 138INDUSTRY 60NIH 10OTHER_GOV 3NETWORK 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Gastrointestinal 1

Conditions

Breast Neoplasms 63Neoplasms 40Colorectal Neoplasms 30Uterine Cervical Neoplasms 29Carcinoma, Hepatocellular 23Stomach Neoplasms 19Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Ovarian Neoplasms 16Lung Neoplasms 14Esophageal Neoplasms 13Multiple Myeloma 12Pancreatic Neoplasms 11Endometrial Neoplasms 10Urinary Bladder Neoplasms 9Motor Activity 9Colonic Neoplasms 9Recurrence 8Rectal Neoplasms 8Lymphoma, Follicular 8Melanoma 7Lymphoma 7Liver Neoplasms 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Sleep Initiation and Maintenance Disorders 6Sarcopenia 6Neuroendocrine Tumors 6Leukemia 6Hematologic Neoplasms 6

Interventions

Cytological Techniques 1Cystoscopy 1Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Kidney Neoplasms × 1 year × Clear all
NCT07485114 2026-03-20

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Tel-Aviv Sourasky Medical Center

Recruiting
300 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Kidney Neoplasms

NCT07284953 2026-03-13

PuraBond

The Royal Wolverhampton Hospitals NHS Trust

Phase NA Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07037589 2025-11-21

BLUSH

Vastra Gotaland Region

Recruiting
300 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡